°Á÷¼º ôÃß¿°¿¡¼ Infliximab »ç¿ë ÈÄ ¹ß»ýÇÑ °Ç¼± 1¿¹
A Case of Infliximab-induced Psoriasis in Treatment of Ankylosing Spondylitis
´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 2014³â 21±Ç 5È£ p.274 ~ p.277
±è¹ÎÁ¤(Kim Min-Jeong) - ¸Þ¸®³îº´¿ø ·ù¸¶Æ¼½º³»°ú
ÀÌÁöÇö(Lee Ji-Hyun) - ¸Þ¸®³îº´¿ø ·ù¸¶Æ¼½º³»°ú
ÀÓÈ£ÁØ(Im Ho-Joon) - ¸Þ¸®³îº´¿ø ·ù¸¶Æ¼½º³»°ú
¿©ÇöÁ¤(Yeo Hyun-Jung) - ¸Þ¸®³îº´¿ø ·ù¸¶Æ¼½º³»°ú
ÀÌÈ«Á÷(Lee Hong-Jik) - ¸Þ¸®³îº´¿ø ·ù¸¶Æ¼½º³»°ú
º¯±â¼·(Byun Gi-Sup) - ¸Þ¸®³îº´¿ø ·ù¸¶Æ¼½º³»°ú
Abstract
InfliximabÀÇ »ç¿ë¿¡ µû¸¥ ºÎÀÛ¿ë Áß ÇǺÎÁúȯÀÌ ³ªÅ¸³ª´Â °ÍÀº µå¹°¸ç ƯÈ÷ °Ç¼±ÀÇ °æ¿ì ¾ÆÁÖ µå¹°°Ô ¹ß»ýÇϳª ÃÖ±Ù ±¹¿Ü º¸°í¿¡¼ ±× ¹ß»ýÀÌ ´Ã¾î³ª´Â Ãß¼¼ÀÌ´Ù. ÀúÀÚµéÀº °Á÷ôÃß¿° ȯÀÚ¿¡¼ infliximab »ç¿ë Áß °Ç¼±ÀÌ ¹ß»ýÇÏ°í Åõ¾à Áß´Ü ÈÄ ÇǺΠº´º¯ÀÌ ¼Ò½ÇµÈ ¿¹¸¦ °æÇèÇÏ¿© À̸¦ º¸°í ÇÏ´Â ¹ÙÀÌ´Ù.
Infliximab, which is indicated for refractory rheumatoid arthritis (RA), ankylosing spondylitis (AS) and Crohn¡¯s disease, has cutaneous adverse events including skin rash, urticaria, pruritus, and lupus-like eruption. Psoriasis in-duced by infliximab is very rare. In Korea, it is in-frequently reported in Crohn¡¯s disease or RA and never reported in AS. We encountered a case of psoriasis induced by infliximab treatment for AS, and report here on this case along with a review of the relevant literature.
Å°¿öµå
Infliximab, Psoriasis, Ankylosing spondylitis
KMID :
0388220140210050274
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)